Successful engraftment following allogeneic stem cell transplantation in very high-risk patients with busulfan as a single agent.
Deeg
Joachim
J
Fred Hutchinson Cancer Research Center, USA. jdeeg@fhcrc.org
D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D002066:Busulfan / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D019337:Hematologic Neoplasms / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D033581:Stem Cell Transplantation / Q000379:methods*; D014184:Transplantation, Homologous
D018906:Antineoplastic Agents, Alkylating; D002066:Busulfan